3,4-二氢-3-甲基-4-氧代咪唑[5,1-d]并[1,2,3,5]四嗪-8-甲酸苯磺酰基呋咱氮氧基酯的合成

以3,4-二氢-3-甲基-4-氧代咪唑[5,1-d]并[1,2,3,5]四嗪-8-甲酰胺和苯磺酰基呋咱氮氧化物为原料,通过肖滕-鲍曼法合成了5种新的咪唑四嗪衍生物——3,4-二氢-3-甲基-4-氧代咪唑[5,1-d]并[1,2,3,5]四嗪-8-甲酸苯磺酰基呋咱氮氧基酯,其结构经1H NMR,IR,MS和元素分析确证。     

3-(2-氟-4-氯-5-取代基苯基)-7-甲基-H3-吡唑并[3,4-d][1,2,3]三嗪-4(7H)-酮化合物的合成及其对原卟啉原氧化酶的抑制活性

为了发现新型的原卟啉原氧化酶抑制剂,根据生物合理设计方法,设计并合成了一系列的结构新颖的3H-吡唑并[3,4-d][1,2,3]三嗪-4-酮衍生物.利用不同取代的5-氨基-吡唑-4-甲酰氯与取代苯胺反应制得的5-氨基-N-苯基-1H-吡唑-4-甲酰胺衍生物,经进一步重氮化得到目标化合物,并对化合物3f进行衍生化.所得目标化合物的结构均经1HNMR,IR和元素分析确证.生物活性测定结果表明,部分化合物对原卟啉原氧化酶有较高的抑制活性,讨论了其结构与活性的关系.     

3-(2-氟-4-氯-5-取代基苯基)-7-甲基-3H-吡唑并[3,4-d][1,2,3]三嗪- 4(7H)-酮化合物的合成及其对原卟啉原氧化酶的抑制活性

为了发现新型的原卟啉原氧化酶抑制剂, 根据生物合理设计方法, 设计并合成了一系列的结构新颖的3H-吡唑并[3,4-d][1,2,3]三嗪-4-酮衍生物. 利用不同取代的5-氨基-吡唑-4-甲酰氯与取代苯胺反应制得的5-氨基-N-苯基-1H-吡 唑-4-甲酰胺衍生物, 经进一步重氮化得到目标化合物, 并对化合物3f进行衍生化. 所得目标化合物的结构均经1H NMR, IR和元素分析确证. 生物活性测定结果表明, 部分化合物对原卟啉原氧化酶有较高的抑制活性, 讨论了其结构与活性的关系.     

3-氨基-6/8取代-1H-吡唑[4,3-c]喹啉类化合物的合成

研究了合成3-氨基-6/8取代-1H-吡唑[4,3-c]喹啉类化合物的简易方法.通过3-芳基-4-氨基-5-巯基-1,2,4-三唑与6-/8-取代-4-羟基喹啉羧酸在三氯氧磷催化下的缩合反应及所生成的3-芳基-6-(6-/8-取代-4-氯喹啉-3-基)-1,2,4-三唑[3,4-b]-1,3,4-噻二唑类化合物与水合肼在乙醇中的肼解反应,合成了6个3-氨基-6/8取代-1H-吡唑[4,3-c]喹啉类化合物,并对活泼的氨基进行了初步研究,新化合物通过元素分析,IR,¹HNMR和MS确定结构,并讨论了其波谱性质.     

3,4-二胺-1H-吡唑并[5,4-d]嘧啶的固相合成

用固相合成技术合成了吡唑并[5,4-d]嘧啶的一类衍生物8.以Merrifield树脂为原料,与化合物3反应得到树脂4.4经过还原胺化、取代、分子内亲核加成反应得到树脂7,再由三氟醋酸断裂得到化合物3,4-二胺-1H-吡唑并[5,4-d]嘧啶.     

多聚磷酸存在下取代6-苄硫基嘧啶与羧酸的环合反应研究

以多聚磷酸(PPA)为催化剂, 对取代6-苄硫基嘧啶与羧酸的反应进行了研究. 当羧酸为脂肪酸时, 在60-80 ℃下反应, 可选择性地得到6-苄硫基嘌呤衍生物; 改用芳香酸时, 则得到硫上的苄基被脱除的6-巯基嘌呤和嘧啶并[5,4-d]噻唑; 如果将嘧啶4-位上伯胺取代基变成仲胺取代基, 只得到嘧啶并[5,4-d]噻唑. 通过双途径反应机理对上述现象进行了解释.     

新型含氮磷杂并环化合物-吡唑并[3,4-d]-1,3,2-二氮磷杂六环-6-酮衍生物的合成研究

本文以异嘌呤类杂环-吡唑并[3,4-d]嘧啶为先导,以1-取代-5-取代氨基-4-(N-烷基)吡唑甲酰胺及取代苯基二氯化膦、六乙基亚磷三酰胺为原料,设计并合成42个新型含氮磷杂并环化合物-吡唑并[3,4-d]-1,3,2-二氮磷杂六环-6-酮衍生物.经1HNMR、IR、MS及元素分析确定了它们的化学结构.初步测定了它们的生物活性.实验表明这些化合物具有一定的抗癌活性及农药活性.     

6-烷氨(氧)基-3-甲硫基-1H-吡唑并[3,4-d]嘧啶-4(5H)-酮衍生物的合成与生物活性

用六氯乙烷、三苯基膦和5-氨基吡唑衍生物一锅法合成关键中间体膦亚胺。 再利用串联aza-Wittig反应,加入对氯苯基异氰酸酯,进一步和烷基胺或取代酚反应合成了11个未见文献报道的6-烷氨（氧）基-3-甲硫基1H-吡唑并[3,4-d]嘧啶-4(5H)-酮衍生物。 通过1H NMR、EI-MS、IR和元素分析等方法对所合成的化合物进行了结构表征,并测试了它们的杀菌和除草活性。 测试结果表明,部分化合物对稗草(barnyard grass)和油菜(Rape)均表现出了较好的抑制活性。     

1-[6-(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪-3-基]酰肼及其衍生物的合成与表征

以水合肼和硝酸胍为原料,经肼化、环化、氧化和肼化四步反应合成了1-[6-(3,5-二甲基-1H吡唑-1-基)-1,2,4,5-四嗪-3-基]酰肼(4);4与酰氯或磺酰氯反应合成了一系列新型的1-[6-(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪-3基]酰肼衍生物(6a～6j),其结构经1H NMR,IR...     

新型氨基功能化碱性离子液体1-(2-氨基乙基)-3-甲基咪唑咪唑盐催化四类取代2-氨基-4H-色烯衍生物的合成

设计合成了阴阳离子均具有碱性位点的新型氨基功能化碱性离子液体1-(2-氨基乙基)-3-甲基咪唑咪唑盐([2-aemim]im,3),经ESIMS和1H NMR确定了结构.[2-aemim]im的碱性与氨基功能化的阳离子([2-amim]+)有关,但主要取决于咪唑阴离子(im-).TG-DSC分析显示[2-aemim]im具有高的热稳定性.将[2-aemim]im用于催化水相介质中芳香醛、丙二腈和酚的三组分一锅法反应制备2-氨基-4H-色烯衍生物,阴阳离子之间表现出协同促进催化作用.该催化剂具有高效和底物作用范围广的特点,应用不同的酚类及类似物,如1-萘酚、2-萘酚、间苯二酚和环己二酮,以高产率得到了相应的不同官能团取代的2-氨基-4H-苯并[h]色烯(4a～4e),2-氨基-4H-苯并[f]色烯(5a～se),2-氨基-4H-色烯(6a～6e)和2-氨基-4H-四氢色烯(7a～7e)四类2-氨基-4H-色烯衍生物.离子液体至少可以循环使用5次,催化活性无显著降低.     

天然5,7-二羟基-3-异戊烯基黄酮与5-羟基-3-异戊烯基黄酮的全合成

以2,4,6-三羟基苯乙酮和2,6-二羟基苯乙酮为原料, 分别通过甲基保护酚羟基、 苯甲酰氯酰化、 Bake-Venkataraman重排、 异戊烯基化、 酸催化关环及EtSLi脱去甲基等6步反应, 以高收率完成了天然5,7-二羟基-3-异戊烯基黄酮(1a, 收率80.6%)和5-羟基-3-异戊烯基黄酮(1b, 收率84.9%)的全合成, 所有化合物均经 ¹H NMR 和 ¹³C NMR表征确定. 通过密度泛函理论方法对目标产物(1a和1b)的生物活性进行了预测. 结果表明, 3位异戊烯基侧链的存在能大大增强化合物相应的生物活性, 而且是化合物生物活性增强必需的取代基. 另外, 目标产物1a的生物活性高于产物1b, 归因于黄酮类化合物分子中A环上的7-OH属增效基团, 起到增强生物活性的作用, 化合物1a分子中A环上有7-OH, 而化合物1b分子中则无该基团. 本合成方法对其它3-烃基黄酮类天然化合物的合成具有潜在的适用性, 所预测的生物活性结果为3-烃基黄酮类化合物的构效关系研究奠定了基础.     

抗癌性吲哚喹唑啉衍生物3D-QSAR研究及其分子设计

吲哚喹唑啉衍生物是近年来发现的一类具有良好抗癌活性的化合物. 作者在最近报道的二维定量构效关系(2D-QSAR)的基础上, 采用比较分子力场方法(CoMFA)进一步对该系列化合物进行三维定量构效关系(3D-QSAR)研究, 建立了3D-QSAR的CoMFA模型, 其非交叉验证相关系数r2=0.986, 标准偏差SD=0.084, 统计方差比F=114.6, 交叉验证相关系数q2=0.695, 表明该模型合理、可信, 并具有良好的预测能力. 研究结果表明: (1) 取代基R1的部位上静电效应起主要作用, 并且确保取代基R1的第一个原子具有较大的净正电荷, 对提高化合物的抗癌活性十分重要. 这与2D-QSAR研究结果相一致. (2) 取代基R2的部位上立体效应起主要作用, R2的体积大小要适中. 应用这些规律进行了分子设计, 在理论上获得了一些具有较高抗癌活性的新的吲哚喹唑啉衍生物, 并期待实验证实. 该QSAR的研究结果可为实验工作者合成新药提供理论参考.     

Novel Synthetic Route to α‐Aminophosphonates Containing Benzothiazole Moiety

A novel and ef?cient synthetic route to α‐aminophosphonates containing benzothiazole moiety via a cascade three‐component reaction from conveniently available starting materials has been developed. The target compounds 3a – 3g , 7 and 8a , 8b were evaluated for their anticancer activities against the cancer cell line HL‐60 in vitro by the MTT method. Compound 3g showed good cancer inhibitory activity against the tested cell line. Further study is necessary to find out the potential antitumor activities.     

Design and Synthesis of 3-Substituedmethylenethiochroman-4-ones as Anticancer Agents

A series of 3-substituedmethylenethiochroman-4-ones was designed and synthesized, and their structures were confirmed by 1H NMR, 13C NMR, MS, IR, UV and elemental analysis. The results of their anticancer activity studies show that almost all 3-chloromethylenethiochroman-4-ones exhibit high anticancer activities and their activities are all better than reference cisplatin. Their IC50 against cancer cells is in a range of 0.80―9.17 μg/mL. Thus they could be promising candidates for anticancer drugs. However, compound 5 has no activity against cancer cells, thus chloromethylene at the 3 position of thiochroman-4-ones seems to play an important role in observed anticancer activities.     

1H and 13C NMR spectral assignment of androstane derivatives

(1)H and (13)C NMR spectroscopic data for 5alpha-androstanes and halo-5alpha-androstanes with different substituents at positions C-3, C-9, C-11 and C-17 were examined and assigned by a combination of 1D and 2D NMR experiments. The substituent effects on the (13)C chemical shifts were compared with those of epi-androsterone, used as a reference compound. The coupling constants (n)J((19)F,(13)C) were measured for compounds 6, 8, 11 and 14.     

Stille coupling reactions in the synthesis of hypoxia-selective 3-alkyl-1,2,4-benzotriazine 1,4-dioxide anticancer agents

The introduction of a 3-alkyl substituent is a key step in the synthesis of 1,2,4-benzotriazine 1,4-dioxide hypoxia-selective anticancer agents, such as SN29751. The Stille reaction of 3-chloro-1,2,4-benzotriazine 1-oxides (BTOs) 5 was inhibited by the presence of electron donating substituents on the benzo ring, thus limiting the range of compounds available for SAR studies. The use of 3-iodo-BTOs 8 did not provide a significant improvement in the yields of 3-ethyl-BTOs 6. Microwave-assisted Stille coupling of chlorides 5 gave dramatically improved yields, which were consistently superior to those from the corresponding iodides 8. The application of microwave-assisted synthesis extended the range of substituted BTOs available for SAR studies and provided an efficient, scalable synthesis of the investigational anticancer agent, SN29751 (1).     

Bromination of 5-Substituted 3H-Furan-2-ones and 3H-Pyrrol-2-ones

The bromination of 5-alkyl(aryl)-3H-furan-2-ones and 5-alkyl(aryl)-3H-pyrrol-2-ones and also their derivatives takes place at the ethylene bond with the formation of 4-monobromo derivatives. N-Phenyl-3H-pyrrol-2-ones are brominated simultaneously at the ethylene bond of the heterocycle and at the phenyl substituent at the nitrogen atom.     

Synthesis and Anticholinesterase Activity of (-)-Physostigmine Analogues with Modifications at C3a and C5

A new series of physostigmine analogues 3a―3j with modifications at the C3a and C5 positions was designed and synthesized. Bioassay of the synthetic analogues 3a―3j, along with the previous synthesized C3a-ethyl-C5-triazole physostigmine analogues 1a―1g and 2a―2j was performed, which indicates that the replacement of the carbamoyl moiety of C3a-ethyl-C5-triazole analogues 1 and 2 with a triazole moiety decreased acetylcholinesterase(AchE) inhibitory activity, whereas the introduction of heterocycles into the triazole ring increased both AChE and butyrylcholinesterase(BchE) inhibitory activities. Structure-activity relationship(SAR) studies of C3a-methyl-C5-triazole analogues 3 reveal the C3a-methyl substituent is important for AChE and BChE inhibition and the introduction of a second ionizable N center improved the binding of the synthetic analogues to both AChE and BChE.     

3-氨磺酰苯甲酸类AKR1C3抑制剂的3D-QSAR和分子对接研究

醛酮还原酶1C3(AKR1C3)作为治疗前列腺癌的新靶点已成为研究热点,3-氨磺酰苯甲酸衍生物对其具有高效的选择性和抑制活性。本文采用比较分子场分析(COMFA)和比较分子相似性指数分析(COMSIA)方法,将经分子对接后的34个优势构象组成训练集和11个优势构象组成测试集,构建三维定量构效关系(3D-QSAR)模型。COMFA模型的交叉验证系数(q2),非交叉验证系数(R2),标准偏差(SEE)和F值分别为0.761,0.973,0.122,185.963;自举法回归系数为R2bs=0.98。最佳组合COMSIA模型的q2,R2,SEE,F和R2bs分别为0.734,0.984,0.097,147.850,0.994。COMFA和COMSIA模型的系统外部测试R2pred分别为0.864和0.756,r2m分别为0.8127和0.5377。这些结果表明,所建立的QSAR模型具有较高的可靠性和较强预测能力。经三维等势图分析可知,在2、5或6位适当增加取代基体积,或在5位引入氢键受体,或在7位引入负电性取代基则能提高化合物的生物活性。该模型为进一步设计具有更优选择性和活性的化合物提供了理论依据。     

3D-QSAR Study on a Series of Indolo[1,2-b]quinazoline Derivatives with Anticancer Activity and their Molecular Design

Indolo[1,2-b]quinazoline derivatives have recently been reported as a type of compound with potential anticancer activity. On the basis of our the published two-dimensional quantitative structure-activity relationship (2D-QSAR) of these compounds, a further study on the three-dimensional quantitative structure-activity relationship (3D-QSAR) was carried out using the method of comparative molecular field analysis (CoMFA). A reasonable, receivable, and an effective 3D-QSAR model has been established, in which the correlation coefficient (r²) and cross-validation coefficient (q²) values are 0.986 and 0.695, respectively, the statistical squared deviation ratio (F) is 114.6, and the standard deviation (SD) is 0.084. The results suggest that the electrostatic effect of substituent R₁ and steric effect of substituent R₂ play a very important role in the improvement of the anticancer activity of these compounds. In this article, some significant conclusions, which are in good agreement with the conclusions obtained using 2D-QSAR, were drawn as follows. (1) The electrostatic effect in the substituent R₁ part plays a major role, and it is very important to make the first atom of R₁ carrying more positive charges in order to improve the anticancer activity of the compounds. (2) The steric effect plays a major role in the substituent R₂ part, and the volume of R₂ should be moderate. Based on the above conclusions, three new molecules of Indolo[1,2-b]quinazoline derivatives with higher anticancer activity have been theoretically designed and are waiting for support from experiment. The QSAR results can offer a theoretical reference for the pharmaceutical synthesis.